Rheumatoid arthritis: vizsgálatok itt: Kína
53 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in KínaMYTP01 for Immune-Mediated Diseases
- Where
- Hangzhou
- Életkor
- 18 év to 65 év
- People
- 160
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT07901764 - No phaseTaking peopleGenAI-Assisted Rheumatoid Arthritis Bone Erosion Risk Assessment and DMARD Selection
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 100
- Run by
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
See details and how to joinNCT07914907 - 1. fázisTaking peopleA Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
- Where
- Beijing, Luoyang, Shanghai, Wuhan
- Életkor
- 18 év to 75 év
- People
- 21 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07363590 · EU 2025-523412-36-00 - 1. fázisTaking peopleStudy Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
- Where
- Beijing, Chengdu, Nanjing
- Életkor
- 18 év to 65 év
- People
- 48 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07201558 · EU 2025-522273-10-00 - 1/2. fázisTaking peopleA Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
- Where
- Beijing, Guangzhou, Nanchang, Shanghai, Zhengzhou
- Életkor
- 18 év to 65 év
- People
- 84 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07412704 · EU 2025-520666-22-00 - 1. fázisTaking peopleA Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 12
- Run by
- China Immunotech (Beijing) Biotechnology Co., Ltd.
See details and how to joinNCT06978647 - 1. fázisTaking peopleA Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Where
- Beijing, Shanghai, Wuhan, Zhengzhou
- Életkor
- 18 év to 70 év
- People
- 72 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06916806 · EU 2024-519015-34-00 - 2. fázisTaking peopleA Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
- Where
- Beijing, Changchun, Changsha, Guangzhou, Jiujiang, Kunming, Linyi, Nanchong, Panjin, Pingxiang, Shantou, Xuzhou, Yangzhou, Zhengzhou
- Életkor
- 18 év and over
- People
- 320 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07276581 - 1. fázisTaking peopleA Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- Where
- Beijing, Changsha, Hefei, Shanghai, Wenzhou, Wuhan
- Életkor
- 18 év to 55 év
- People
- 68 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07276958 · EU 2026-527207-25-00 - 2. fázisTaking peopleSafety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 24
- Run by
- Toll Biotech Co. Ltd. (Beijing)
See details and how to joinNCT07408024 - 2. fázisTaking peopleA Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 32
- Run by
- Jacobio Pharmaceuticals Co., Ltd.
See details and how to joinNCT07684157 - 2. fázisCsak meghívásosTLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 90
- Run by
- Hangzhou Highlightll Pharmaceutical Co., Ltd
See details and how to joinNCT07748728 - 2. fázisTaking peopleFaecal Microbiota Transplantation in Patients With Refractory Rheumatoid Arthritis
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 40
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07639177 - 4. fázisNot yet taking people in KínaTreatment Strategy for Patients With RA-ILD
- Where
- Beijing, Changchun, Chongqing, Dalian, Handan, Hangzhou, Hefei, Hohhot, Jiujiang, Lanzhou, Luoyang, Nanchang, Nanjing, Nanning, Taiyuan, Ürümqi, Xingyi, Yan’an, Yinchuan
- Életkor
- 18 év to 80 év
- People
- 204
- Run by
- Chinese SLE Treatment And Research Group
See details and how to joinNCT07643038 - 2. fázisTaking peopleEfficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
- Where
- Beijing, Changchun, Changsha, Chongqing, Dalian, Dongying, Guangzhou, Haikou, Harbin, Hefei, Hengyang, Huaihua, Jiangmen, Kaifeng, Kunming, Linfen, Linyi, Nanchang, Nanning, Nantong, Ningbo, Qingdao, Quanzhou, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Taiyuan, Ürümqi, Weifang, Wenzhou, Wuhan, Yangzhou, Yantai, Zhengzhou, Zibo
- Életkor
- 18 év and over
- People
- 420
- Run by
- Peking University People's Hospital
See details and how to joinNCT07796516 - No phaseCsak meghívásosMass Spectrometry-based Immune Profiling in Autoimmune Diseases
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 500
- Run by
- Peking University People's Hospital
See details and how to joinNCT07188285 - 1. fázisTaking peopleEfficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）
- Where
- Hefei
- Életkor
- 18 év to 69 év
- People
- 30
- Run by
- Shenzhen MagicRNA Biotechnology Co., Ltd
See details and how to joinNCT06801119 - 4. fázisTaking peopleIntegrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 300
- Run by
- Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
See details and how to joinNCT07721142 - No phaseTaking peopleClinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 10 000
- Run by
- Dongyi He
See details and how to joinNCT07484243 - 2. fázisTaking peoplePhase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 450
- Run by
- Changchun GeneScience Pharmaceutical Co., Ltd.
See details and how to joinNCT07423533 - No phaseNot yet taking people in KínaA Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 75
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT07593911 - No phaseTaking peopleMethotrexate Combined With Tofacitinib in Rheumatoid Arthritis
- Where
- Foshan, Guangzhou, Jieyang, Shantou
- Életkor
- 18 év to 65 év
- People
- 130
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06301373 - No phaseTaking peopleExploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
- Where
- Nanjing
- Életkor
- 18 év to 70 év
- People
- 72
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07558850 - No phaseTaking peopleFucoidan in the Treatment of Active Rheumatoid Arthritis
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 40
- Run by
- Peking University People's Hospital
See details and how to joinNCT07045896 - No phaseTaking peopleProspective Cohort Study on Refractory Rheumatoid Arthritis
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 200
- Run by
- Peking University Third Hospital
See details and how to joinNCT07126431